Investigational PDE4 Inhibitor Shows Promise for Some COPD Patients, University Hospital Aintree Study

MedPage Today -- An investigational phosphodiesterase 4 (PDE4) inhibitor called roflumilast may help some patients with chronic obstructive pulmonary disease, four multicenter, randomized controlled trials showed.

MORE ON THIS TOPIC